Litecoin price surged 5% to $118 as buying pressure mounted, driven by whale accumulation and exchange-traded fund anticipation. The price broke above a key resistance area of $113-$115, with whales accumulating 181,000 additional coins on September 9. Grayscale's ETF filings and MEI Pharma's $100M Litecoin treasury strategy have also contributed to the rally.
Litecoin (LTC) price experienced a significant surge, rising by 5% to $118 on September 9, 2025. The price break above the key resistance area of $113-$115 was driven by substantial buying pressure, primarily attributed to whale accumulation and anticipation of exchange-traded fund (ETF) listings. According to LookOnChain, a whale spent $2 million to purchase 7.4 million WLFI tokens three days prior, holding an unrealized loss of over $650,000
An whale bought WLFI three days ago, spending $2 million. They are currently facing an unrealized loss of over $650,000.[1]. This large-scale accumulation has been a notable factor in the recent price rally.
Additionally, Grayscale's ETF filings and MEI Pharma's $100 million Litecoin treasury strategy have contributed to the bullish sentiment. MEI Pharma, a publicly traded pharmaceutical company, has integrated Litecoin into its treasury operations, becoming the first and only publicly traded company to adopt Litecoin as a treasury reserve asset
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange[2]. The company's strategic move, led by Charlie Lee, the founder of Litecoin, and GSR as its digital asset and treasury management advisor, has garnered significant attention and confidence in the cryptocurrency.
The price surge is also indicative of growing institutional interest in Litecoin. The company's strategic move, coupled with the potential for Grayscale's ETF listings, has led to increased demand and buying pressure. As Litecoin continues to demonstrate its value as a fast, secure, and decentralized cryptocurrency, investors are showing increased confidence in its long-term potential.
In summary, the recent surge in Litecoin price is a result of whale accumulation, ETF anticipation, and MEI Pharma's strategic integration of Litecoin into its treasury operations. As institutional interest and confidence in Litecoin grow, the cryptocurrency is poised for further price appreciation and broader adoption.
Comments
No comments yet